Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations

World Journal of Gastroenterology

Volumn 11, Issue 3, 2005, Pages 393-395

  Duseja, Ajay ^a   Das, Reena ^a   Nanda, Mohit ^a   Das, Ashim ^a   Garewal, Gurjeewan ^a   Chawla, Yogesh ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

HFE gene; Iron overload; Mutation; Nonalcoholic steatohepatitis

Indexed keywords

FERRITIN; HFE PROTEIN; IRON; IRON BINDING PROTEIN; TRANSFERRIN;

ADULT; AGED; ARTICLE; ASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; GENE MUTATION; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INDIAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON OVERLOAD; LIVER BIOPSY; LIVER FIBROSIS; MALE; NONALCOHOLIC FATTY LIVER;

EID: 12344257645     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i3.393     Document Type: Article

References (23)

1. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis. Mayo Clinic experience with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-438
2. Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 2001; 21: 27-41
3. Day CP, James OF. Steatohepatitis: a tale of two "hits"? (editorial). Gastroenterology 1998; 114: 842-845
4. Blendis L, Oren R, Halpern Z. NASH: Can we iron out the pathogenesis? Gastroenterology 2000; 118: 981-983
5. Chitturi S, Weltman M, Farrell GC, McDonald D, Kench J, Liddle C, Samarasinghe D, Lin R, Abeygunasekera S, George J. HFE mutations, hepatic iron, and fibrosis: Ethnic specific association of NASH with C282Y but not with fibrotic severity. Hepatology 2002; 36: 142-149
6. Amrapurkar DN, Amrapurkar AD. Nonalcoholic steatohepaitis: clinicopathological profile. J Assoc Physicians India 2000; 48: 311-313
7. Agarwal SR, Malhotra V, Sakhuja P, Sarin SK. Clinical, biochemical and histological profile of nonalcoholic steatohepatitis. Indian J Gastroenterol 2001; 20: 183-186
8. Dacie JV, Lewis SM, Hoffbrand AV. Investigation of megaloblastic and iron deficiency anemias. In Dacie JV, Lewis SM (eds): Practical Hematology Churchil Livingstone: Singapore 1984: 313-336
9. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Wolff RK. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. Nat Genet 1996; 13: 399-408
10. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-2474
11. Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N Eng J Med 1999; 341: 427-434
12. World Health Organisation. Definition, diagnosis and classification of diabetes mellitus and its complications-Part 1: Diagnosis and classification of diabetes mellitus. Geneva: World Health Organisation 1999: 31-33
13. Diabetes care: report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2002; 25: S5-S20
14. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, Karim R, Lin R, Samarasinghe D, Liddle C, Weltman M, George J. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 35: 373-379
15. James OF, Day CP. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatol 1998; 29: 495-501
16. George DK, Goldwurm S, MacDonald GA, Cowley LL, Walker NI, Ward PJ, Jazwinska EC, Powell LW. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998; 114: 311-318
17. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994; 107: 1103-1109
18. Fargion S, Mattioli M, Fracanzani AL, Sampietro M, Tavazzi D, Fociani P, Taioli E, Valenti L, Fiorelli G. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol 2001; 96: 2448-2455
19. Younossi ZM, Gramlich T, Bacon BR, Matteoni CA, Boparai N, O'Neill R, McCullough AJ. Hepatic iron and nonalcoholic fatty liver disease. Hepatology 1999; 30: 847-850
20. Bacon BR. Hemochromatosis: diagnosis and management. Gastroenterology 2001; 120: 718-725
21. Mendler MH, Turlin B, Moirand R, Jouanolle AM, Sapey T, Guyader D, Le Gall JY, Brissot P, David V, Deugnier Y. Insulin resistance-associated hepatic iron overload. Gastroenterology 1999; 117: 1155-1163
22. Bonkovsky HL, Jawaid Q, Tortorelli K, LeClair P, Cobb J, Lambrecht RW, Banner BF. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Hepatol 1999; 31: 421-429
23. Garewal G, Das R, Kaur J, Chawla Y. H63D mutation of the HFE gene in beta thalassamia traits does not cause iron overload and the hereditary haemochromatosis in North India is of the non-HFE gene type. Blood 2002; 100: 46